Technology spillovers and capital gains in corporate venture capital investments : evidence from the biopharmaceutical industry
Year of publication: |
2021
|
---|---|
Authors: | Kang, Hyunsung D. ; Nanda, Vikram ; Park, Haemin D. |
Published in: |
Venture capital : an international journal of entrepreneurial finance. - London [u.a.] : Taylor & Francis, ISSN 1464-5343, ZDB-ID 2032399-2. - Vol. 23.2021, 2, p. 129-155
|
Subject: | appropriation | biopharmaceutical industry | capital gain | Corporate venture capital | technology spillover | Risikokapital | Venture capital | Spillover-Effekt | Spillover effect | Biotechnologie-Industrie | Biotechnology industry | Investition | Investment | Wertzuwachssteuer | Capital gains tax | Pharmaindustrie | Pharmaceutical industry | Technologietransfer | Technology transfer |
-
Baldi, Francesco, (2015)
-
Technology acquisition following inventor exit in the biopharmaceutical industry
Varshney, Mayank, (2023)
-
Kang, Hyunsung D., (2018)
- More ...
-
A high-tech start-up's debt financing strategy: Implications for valuing soft information
Kang, Hyunsung D., (2017)
-
Corporate venture capital as a real option in the markets for technology
Ceccagnoli, Marco, (2018)
-
Corporate venture capital as a real option in the markets for technology
Ceccagnoli, Marco, (2015)
- More ...